一个无底井:1,2,4-三醇继续激励科学研究人员开发越来越多的抗癌分子
1Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City 11884, Cairo, Egypt; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Horus University-Egypt, International Coastal Road, New Damietta 34518, Egypt.
Bioorganic & medicinal chemistry
|September 16, 2025
概括
本综述强调了2020-2025年间合成的200多种新型1,2,4-三抗癌候选药物. 这些化合物向VEGFR和EGFR等关键途径,提供有前途的治疗潜力.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 1,2,4-Triazoles是药物化学中的多功能支架,以各种生物活动而闻名.
- 抗癌药物开发是研究的一个关键领域,寻找新的治疗剂.
- 近年来,三醇衍生物的合成和评估取得了重大进展.
研究的目的:
- 为了提供最近 (2020-2025) 1,2,4-triazole抗癌候选人的全面概述.
- 探索这些化合物的合成策略和生物活性评估.
- 讨论它们的作用机制和潜在的治疗应用.
主要方法:
- 2020-2025年科学出版物的文献综述,重点关注1,2,4-triazoles和抗癌活性.
- 分析用于产生新型三醇衍生物的合成方法.
- 对各种癌症标进行生物活性数据的编制和评估.
主要成果:
- 在指定的期间报告了200多种1,2,4-triazole抗癌候选药物.
- 这些候选药物向不同的生物途径,包括A2B,STAT,VEGFR,EGFR,p97,芳酶和铁灭.
- 讨论了对这些衍生物的抗癌作用的机制性见解.
结论:
- 1,2,4-三醇是潜在的抗癌药物的丰富来源.
- 了解它们的目标和机制对于未来的药物开发至关重要.
- 本综述旨在指导和激发这一有前途的领域的进一步研究.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.6K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para...
3.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


